Back to Search Start Over

Re-irradiation for Locally Recurrent Lung Cancer: Evidence, Risks and Benefits.

Authors :
Rulach R
Hanna GG
Franks K
McAleese J
Harrow S
Source :
Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2018 Feb; Vol. 30 (2), pp. 101-109. Date of Electronic Publication: 2017 Dec 06.
Publication Year :
2018

Abstract

In spite of recent improvements in both the technical delivery of radiotherapy and systemic therapy in the treatment of non-small cell lung cancer, local recurrence rates after radiotherapy remain a significant challenge. In the setting of local relapse after radiotherapy, treatments such as surgical resection or radiofrequency ablation are often not appropriate owing to disease and patient factors. Re-irradiation may be a potential treatment option. This overview considers the published evidence and potential treatment strategies.<br /> (Copyright © 2017 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1433-2981
Volume :
30
Issue :
2
Database :
MEDLINE
Journal :
Clinical oncology (Royal College of Radiologists (Great Britain))
Publication Type :
Academic Journal
Accession number :
29223641
Full Text :
https://doi.org/10.1016/j.clon.2017.11.003